Biomaterials Market is anticipated to value over USD 208 billion at a CAGR of over 14.2% during the forecast period 2020 to 2027.

Biomaterials are a vital part of the medical industry. Most of biomaterials are medical implants for therapeutic or diagnostic purposes. Catheters, cardiac valves, ligaments, scaffolds and so on are examples of commonly used biomaterials.

The new research in medical implants, increasing cases of cardiovascular and orthopedic diseases across the globe, targeted drug delivery, etc. are driving factors for the growth of the market. Furthermore, the advances in diagnostic research related to biomaterials has driven its preference by end users.

The natural biomaterials have a variety of applications based on the material used like silk, collagen, fibrin, etc..The targeted delivery by collagen fibers is the key factor for the demand of natural biomaterials. Currently, the biomaterial scaffolds that are used to modulate cancer are in trend. Rising cancer risk and awareness are anticipated drivers for natural biomaterials demand.

Based on applications, the rising population of the cardiac and orthopedic patients dominates the growth of the market. There is a widespread availability of products for treatment and the expenses spent on them contribute to a large market share of biomaterials across the globe.

North America dominates the global market due to the increasing incidences of cardiovascular diseases in the region. Asia Pacific region has a large population across the globe and also the risk of adopting cardiovascular and other diseases. This boosts the market of biomaterials in the Asia Pacific region.

Major companies marketing for biomaterials are Royal DSM, BASF SE,  Corbion Berkeley Advanced Biomaterials, Inc., Cam Bioceramics B.V. and so on.  Royal DSM is anticipated to be a major competitor in the market. It has products for cardiac rhythm management (shunts, implantable cardiac defibrillators, vascular puncture closure devices, etc.), intraocular lens and corneal procedures, joint repair and so on. This range of advanced products is the key to market growth.   

FutureWise Key Takeaways:

  • Investment in cardiac and orthopedic biomaterials marketing
  • Focus on natural biomaterials research

Competitive Landscape:

  • Tier 1 players- established companies in the market
  • Laboratories and Agilent Technologies, Inc. with a major market share 
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

Biomaterials Market

Biomaterials Market Segmentation:

By Type

  • Metallic
  • Polymeric
  • Ceramic
  • Natural biomaterials

By Application

  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Plastic surgery
  • Wound healing
  • Tissue engineering
  • Neurological/ central nervous system applications
  • Other applications

By Region

  • North America
  • Europe
  • Asia Pacific

Objectives of the Study:

  • To provide with an exhaustive analysis on the biomaterials market by type, by application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Asia Pacific and Europe
  • To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • Profiling of companies to evaluate their market shares, strategies, financials and core competencies


Need Assistance


UK : +44 141 628 9353
US : +1 347 709 4931


Contact Sales

What you get

  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included

  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics